(Q76394083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

Genetic testing for cancer susceptibility: the promise and the pitfalls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Caryn Lerman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Alexandra E Shields

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

235-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc1301

24 November 2019

exact match

0 references

cites work

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

1 reference

31 March 2020

1 reference

Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer

31 March 2020

1 reference

Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates

31 March 2020

1 reference

Attitudes Toward Genetic Testing in Patients At Risk for HNPCC/FAP and the German Population

31 March 2020

1 reference

Genetic testing in families with hereditary nonpolyposis colon cancer

31 March 2020

1 reference

Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.

31 March 2020

1 reference

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

31 March 2020

1 reference

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

31 March 2020

1 reference

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

31 March 2020

1 reference

Early adoption of BRCA1/2 testing: who and why.

31 March 2020

1 reference

Identification and referral of families at high risk for cancer susceptibility

31 March 2020

1 reference

Psychological impact of genetic testing in women from high-risk breast cancer families.

31 March 2020

1 reference

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing

31 March 2020

1 reference

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

31 March 2020

1 reference

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs

31 March 2020

1 reference

Genetic risk and behavioural change

31 March 2020

1 reference

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

31 March 2020

1 reference

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

31 March 2020

1 reference

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

31 March 2020

1 reference

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

31 March 2020

1 reference

Women at risk of ovarian cancer: attitudes towards and expectations of the familial ovarian cancer clinic

31 March 2020

1 reference

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer

31 March 2020

1 reference

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment

31 March 2020

1 reference

Impact of genetic counseling and testing on colorectal cancer screening behavior

31 March 2020

1 reference

Understanding why negative genetic test results sometimes fail to reassure.

31 March 2020

1 reference

Protecting privacy to improve health care.

31 March 2020

1 reference

Genetic discrimination and health insurance: an urgent need for reform.

31 March 2020

1 reference

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

31 March 2020

1 reference

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.

31 March 2020

1 reference

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

31 March 2020

1 reference

The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews

31 March 2020

1 reference

The importance of race and ethnic background in biomedical research and clinical practice

31 March 2020

1 reference

31 March 2020

1 reference

Categorization of humans in biomedical research: genes, race and disease

31 March 2020

1 reference

A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing

31 March 2020

1 reference

A systematic review of the literature exploring the role of primary care in genetic services

31 March 2020

1 reference

Are General Practitioners Willing and Able to Provide Genetic Services for Common Diseases?

31 March 2020

1 reference

Genetic counselling protocols for hereditary non‐polyposis colorectal cancer: a survey of UK regional genetics centres

31 March 2020

1 reference

Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland

31 March 2020

1 reference

Elucidating the role of genetic factors in smoking behavior and nicotine dependence

31 March 2020

1 reference

5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol

31 March 2020

1 reference

Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication.

31 March 2020

1 reference

The dopamine D2 receptor gene: a genetic risk factor in substance abuse.

31 March 2020

1 reference

US physicians' attitudes toward genetic testing for cancer susceptibility.

31 March 2020

1 reference

Genetics education for primary-care providers

31 March 2020

1 reference

Population screening in the age of genomic medicine

31 March 2020

1 reference

“Cancer in the family” and genetic testing: implications for life insurance

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC1301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993905%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 November 2019

0 references

1 reference